A Comparison Between Recombinant
Adjuvants, Immunologic
Animals
Antibodies, Bacterial
/ blood
Antigens, Bacterial
/ genetics
Bacterial Infections
/ prevention & control
Bacterial Vaccines
/ administration & dosage
CD4-Positive T-Lymphocytes
/ immunology
CD8-Positive T-Lymphocytes
/ immunology
Cross Protection
Cross Reactions
Dendritic Cells
/ immunology
Glyceraldehyde-3-Phosphate Dehydrogenases
/ genetics
Interferon-gamma
/ immunology
Lipids
/ chemistry
Listeria
/ enzymology
Mice
Mycobacterium
/ immunology
RNA, Messenger
/ chemistry
Recombinant Proteins
/ genetics
Streptococcus
/ immunology
cross-reactive vaccines
glyceraldehyde-3-phosphate-dehydrogenase
innate immunity
listeriosis
pneumonia
tuberculosis
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2021
2021
Historique:
received:
23
11
2020
accepted:
15
02
2021
entrez:
6
5
2021
pubmed:
7
5
2021
medline:
18
9
2021
Statut:
epublish
Résumé
Cross-reactive vaccines recognize common molecular patterns in pathogens and are able to confer broad spectrum protection against different infections. Antigens common to pathogenic bacteria that induce broad immune responses, such as the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) of the genera
Identifiants
pubmed: 33953709
doi: 10.3389/fimmu.2021.632304
pmc: PMC8092121
doi:
Substances chimiques
Adjuvants, Immunologic
0
Antibodies, Bacterial
0
Antigens, Bacterial
0
Bacterial Vaccines
0
Lipids
0
RNA, Messenger
0
Recombinant Proteins
0
Interferon-gamma
82115-62-6
Glyceraldehyde-3-Phosphate Dehydrogenases
EC 1.2.1.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
632304Informations de copyright
Copyright © 2021 Teran-Navarro, Salcines-Cuevas, Calderon-Gonzalez, Tobes, Calvo-Montes, Pérez-Del Molino Bernal, Yañez-Diaz, Fresno and Alvarez-Dominguez.
Déclaration de conflit d'intérêts
MF was employed by company DIOMUNE S.L. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Nanomaterials (Basel). 2016 Aug 19;6(8):
pubmed: 28335280
medRxiv. 2020 May 16;:
pubmed: 32511573
BMC Bioinformatics. 2005 May 31;6:132
pubmed: 15927070
Mol Pharm. 2005 Jan-Feb;2(1):74-82
pubmed: 15804180
J Nanobiotechnology. 2016 Jul 27;14(1):61
pubmed: 27465605
Nat Rev Drug Discov. 2018 Apr;17(4):261-279
pubmed: 29326426
Vaccine. 2015 Mar 17;33(12):1465-73
pubmed: 25659269
Front Immunol. 2020 Oct 02;11:579250
pubmed: 33123165
J Immunol Methods. 2015 Jan;416:105-23
pubmed: 25445329
Oncotarget. 2017 Jul 20;8(33):53916-53934
pubmed: 28903312
Front Immunol. 2016 Nov 29;7:541
pubmed: 27965668
Dermatol Clin. 2015 Jul;33(3):563-77
pubmed: 26143432
Immun Ageing. 2018 Jan 22;15:3
pubmed: 29387135
Science. 2016 Apr 22;352(6284):aaf1098
pubmed: 27102489
Traffic. 2008 Mar;9(3):325-37
pubmed: 18088303
Front Immunol. 2018 Dec 17;9:2936
pubmed: 30619296
Nanoscale. 2017 Aug 3;9(30):10721-10732
pubmed: 28714508
Curr Drug Targets. 2014;15(12):1132-43
pubmed: 25330031
Nucleic Acids Res. 2021 Jan 8;49(D1):D344-D354
pubmed: 33156333
Vaccine. 2012 Mar 30;30(16):2633-9
pubmed: 22365841
Immune Netw. 2018 Apr 03;18(2):e17
pubmed: 29732235
J Immunol Methods. 2015 Sep;424:111-9
pubmed: 26031451
PLoS One. 2019 Feb 8;14(2):e0211714
pubmed: 30735507
J Biol Chem. 1999 Apr 23;274(17):11459-62
pubmed: 10206948
J Clin Microbiol. 2013 Nov;51(11):3591-6
pubmed: 23966491
PLoS One. 2017 Jul 25;12(7):e0181942
pubmed: 28742838
Curr Pharm Des. 2016;22(41):6283-6293
pubmed: 27573928
Biochem Biophys Res Commun. 2011 Dec 9;416(1-2):178-83
pubmed: 22093830
PLoS One. 2015 Dec 16;10(12):e0144196
pubmed: 26673420
Eur J Immunol. 2018 Jan;48(1):180-193
pubmed: 28799230
Clin Infect Dis. 2010 Jul 1;51(1):58-65
pubmed: 20491545
Vaccine. 2001 Feb 28;19(15-16):2020-8
pubmed: 11228373
Front Cell Infect Microbiol. 2020 Oct 28;10:573348
pubmed: 33194812
mSphere. 2018 Jul 25;3(4):
pubmed: 30045966
J Immunol. 2003 Jul 1;171(1):291-8
pubmed: 12817010
Front Cell Infect Microbiol. 2014 Feb 21;4:22
pubmed: 24600592
Hum Vaccin Immunother. 2015;11(10):2501-3
pubmed: 26252360
Chem Commun (Camb). 2010 Jun 21;46(23):4151-3
pubmed: 20454745
Expert Rev Vaccines. 2015 Feb;14(2):221-34
pubmed: 25540984
Bioorg Chem. 2021 Jan;106:104463
pubmed: 33213896
Clin Exp Immunol. 2011 Apr;164(1):100–7
pubmed: 21391984
Lancet. 2017 Dec 17;388(10063):3036-3047
pubmed: 27265346
Nat Rev Immunol. 2020 Jun;20(6):335-337
pubmed: 32393823
J Mol Med (Berl). 2010 Feb;88(2):143-7
pubmed: 20066390
EMBO Mol Med. 2020 Jun 8;12(6):e12661
pubmed: 32379923